Ikaria takes a $1.6B buyout but spins out some early-stage programs

Damian Garde

Rumored takeover target has signed a deal to sell the majority of its business to a private equity outfit for about $ 1.6 billion, spinning out a new company to work on in-development candidates.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS